Investor Information

IR banner
Webcast ImageWebcast - Replay
Q4 2016 Express Scripts Holding Co Earnings Conference Call
02/15/17 at 8:30 a.m. ET
Q4 2016 Express Scripts Holding Co Earnings Conference Call
Wednesday, February 15, 2017 8:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Business Overview

Business Overview
At Express Scripts we believe in practicing pharmacy smarter. We put medicine within reach of tens of millions of people by aligning with our customers, taking bold action and delivering patient-centered care to make better health more affordable and accessible.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

Stock chart for: ESRX.O.  Currently trading at $70.93 with a 52 week high of $80.02 and a 52 week low of $64.46.
ESRX (Common Stock)
ExchangeNASDAQ (US Dollar)
Change (%) Stock is Up 0.20 (0.28%)
Data as of 02/23/17 4:00 p.m. ET
Refresh quote
Recent Press Releases
Express Scripts Named one of Fortune Magazine's World's Most Admired Companies of 2017 - 02/16/2017 - 4:12 p.m.
ST. LOUIS, Feb. 16, 2017 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) was recognized today by Fortune Magazine as one of the World's Most Admired Companies within the Health Care: Pharmacy and Other... 
Express Scripts Announces 2016 Fourth Quarter and Full Year Results - 02/14/2017 - 4:01 p.m.
ST. LOUIS, Feb. 14, 2017 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2016 fourth quarter and full year net income of $1,434.7 million and $3,404.4 million, respectively, o... 
Express Scripts Fights Back Against Irresponsible Drug Pricing; Holds U.S. Drug Spending Increase to 3.8 Percent in 2016 - 02/06/2017 - 6:01 a.m.
- Patients' share of cost for prescription drugs declined for the second consecutive year - Despite brand-name list price increases of nearly 11 percent, Express Scripts kept unit cost increases fo... 
Express Scripts Holding Company Announces Fourth Quarter and Full Year 2016 Earnings Conference Call - 01/18/2017 - 11:12 a.m.
ST. LOUIS, Jan. 18, 2017 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq:ESRX) (“Express Scripts”) announced today its intention to release its 2016 fourth quarter and full year financia... 
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Express Scripts Holding Co posts new information to the site. Just enter your e-mail address and click Submit.

Tax Consequences of Express Scripts and Medco Merger

Investor Overview
Learn more about Express Scripts and find corporate and shareholder information.

Data provided by Nasdaq. Minimum 15 minutes delayed.
Print Page Print | E-mail Page E-mail Page | RSS Feeds RSS | E-mail Alerts Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet